Riverwater Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,643
| Closed | -$1.09M | – | 219 |
|
|
2024
Q3 | $1.09M | Buy |
5,643
+126
| +2% | +$24.3K | 0.54% | 57 |
|
|
2024
Q2 | $1.14M | Buy |
5,517
+1,878
| +52% | +$388K | 0.84% | 27 |
|
|
2024
Q1 | $986K | Buy |
3,639
+32
| +0.9% | +$8.67K | 0.72% | 32 |
|
|
2023
Q4 | $853K | Buy |
3,607
+24
| +0.7% | +$5.67K | 0.67% | 40 |
|
|
2023
Q3 | $702K | Sell |
3,583
-42
| -1% | -$8.23K | 0.64% | 40 |
|
|
2023
Q2 | $762K | Buy |
3,625
+171
| +5% | +$36K | 0.68% | 42 |
|
|
2023
Q1 | $697K | Buy |
3,454
+19
| +0.6% | +$3.84K | 0.64% | 46 |
|
|
2022
Q4 | $748K | Buy |
3,435
+130
| +4% | +$28.3K | 0.64% | 41 |
|
|
2022
Q3 | $650K | Buy |
3,305
+1,232
| +59% | +$242K | 0.65% | 48 |
|
|
2022
Q2 | $444K | Buy |
2,073
+157
| +8% | +$33.6K | 0.45% | 69 |
|
|
2022
Q1 | $544K | Sell |
1,916
-1,900
| -50% | -$539K | 0.9% | 47 |
|
|
2021
Q4 | $1.44M | Buy |
+3,816
| New | +$1.44M | 1.28% | 10 |
|